MC4R变异在多水平调节α-MSH和司美拉诺肽诱导的细胞信号传导
研究对17个肥胖相关MC4R变异进行功能分析,检测细胞表面表达、α-MSH或司美拉诺肽诱导的cAMP反应、β-抑制蛋白2招募和ERK激活。变异功能异质性大,但患者肥胖表型无明显差异。司美拉诺肽效力高于α-MSH,对部分变异诱导的cAMP最大反应显著增加。
要点
- 肥胖相关MC4R变异对多条信号通路影响各异,但临床肥胖表型相似。
- 司美拉诺肽效力高于α-MSH,对部分变异cAMP最大反应显著增加。
- 评估MC4R变异对多种信号机制的影响有助于判断其与肥胖的关联。
核心结论
- 肥胖相关MC4R变异以不同方式影响MC4R信号传导,但导致相似的临床表型。
- 评估MC4R变异对多种分子信号机制的影响对确定其与肥胖的关联具有临床重要性,可能有助于改善个体化治疗。
研究设计与样本
- 在表达野生型或变异型MC4R的细胞中,检测细胞表面表达、α-MSH或司美拉诺肽诱导的cAMP反应、β-抑制蛋白2招募和ERK激活。
- 在成人和儿童肥胖患者中鉴定出17个MC4R变异。
主要发现
- 变异功能异质性大:部分变异所有 studied MC4R信号均丧失反应。
- 部分变异无cAMP蓄积或ERK激活但β-抑制蛋白2招募正常。
- 部分变异cAMP蓄积和ERK激活正常但β-抑制蛋白2招募降低,提示脱敏和信号机制受损。
- 司美拉诺肽效力高于α-MSH、效能相似,对部分变异诱导的cAMP最大反应较α-MSH显著增加。
- 尽管功能反应异质,患者肥胖表型无明显差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The melanocortin-4 receptor (MC4R) plays an important role in body weight regulation. Pathogenic MC4R variants are the most common cause of monogenic obesity. OBJECTIVE: We have identified 17 MC4R variants in adult and pediatric patients with obesity. Here we aimed to functionally characterize these variants by analyzing 4 different aspects of MC4R signaling. In addition, we aimed to analyze the effect of setmelanotide, a potent MC4R agonist, on these MC4R variants. MATERIALS AND METHODS: Cell surface expression and α-melanocyte stimulating hormone (α-MSH)- or setmelanotide-induced cAMP response, β-arrestin-2 recruitment, and ERK activation were measured in cells expressing either wild type or variant MC4R. RESULTS: We found a large heterogeneity in the function of these variants. We identified variants with a loss of response for all studied MC4R signaling, variants with no cAMP accumulation or ERK activation but normal β-arrestin-2 recruitment, and variants with normal cAMP accumulation and ERK activation but decreased β-arrestin-2 recruitment, indicating disrupted desensitization and signaling mechanisms. Setmelanotide displayed a greater potency and similar efficacy as α-MSH and induced significantly increased maximal cAMP responses of several variants compared to α-MSH. Despite the heterogeneity in functional response, there was no apparent difference in the obesity phenotype in our patients. CONCLUSION: We show that these obesity-associated MC4R variants affect MC4R signaling differently yet lead to a comparable clinical phenotype. Our results demonstrate the clinical importance of assessing the effect of MC4R variants on a range of molecular signaling mechanisms to determine their association with obesity, which may aid in improving personalized treatment.
引用
- Rodríguez Rondón AV, Welling MS, van den Akker ELT, et al. MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels. J Clin Endocrinol Metab. 2024. PMID: 38567654. doi:10.1210/clinem/dgae210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。